InfuSystem (INFU) Competitors $5.07 +0.27 (+5.63%) Closing price 04:00 PM EasternExtended Trading$5.04 -0.03 (-0.49%) As of 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock INFU vs. DCTH, NPCE, SMLR, CLPT, CVRX, TCMD, SNWV, ZIMV, NNOX, and SMTIShould you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include Delcath Systems (DCTH), NeuroPace (NPCE), Semler Scientific (SMLR), ClearPoint Neuro (CLPT), CVRx (CVRX), Tactile Systems Technology (TCMD), SANUWAVE Health (SNWV), ZimVie (ZIMV), Nano-X Imaging (NNOX), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry. InfuSystem vs. Delcath Systems NeuroPace Semler Scientific ClearPoint Neuro CVRx Tactile Systems Technology SANUWAVE Health ZimVie Nano-X Imaging Sanara MedTech Delcath Systems (NASDAQ:DCTH) and InfuSystem (NYSE:INFU) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, community ranking, media sentiment, valuation, risk, analyst recommendations and institutional ownership. Is DCTH or INFU more profitable? InfuSystem has a net margin of 1.12% compared to Delcath Systems' net margin of -150.70%. InfuSystem's return on equity of 2.78% beat Delcath Systems' return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems-150.70% -338.16% -104.02% InfuSystem 1.12%2.78%1.41% Does the media prefer DCTH or INFU? In the previous week, Delcath Systems had 4 more articles in the media than InfuSystem. MarketBeat recorded 4 mentions for Delcath Systems and 0 mentions for InfuSystem. Delcath Systems' average media sentiment score of 1.65 beat InfuSystem's score of 0.00 indicating that Delcath Systems is being referred to more favorably in the media. Company Overall Sentiment Delcath Systems Very Positive InfuSystem Neutral Which has higher valuation and earnings, DCTH or INFU? InfuSystem has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$37.21M10.25-$47.68M-$0.98-11.64InfuSystem$134.86M0.79$870K$0.1050.70 Do analysts recommend DCTH or INFU? Delcath Systems currently has a consensus price target of $22.75, indicating a potential upside of 99.39%. InfuSystem has a consensus price target of $13.00, indicating a potential upside of 156.41%. Given InfuSystem's stronger consensus rating and higher probable upside, analysts clearly believe InfuSystem is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00InfuSystem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 3 Strong Buy rating(s) 4.00 Which has more risk & volatility, DCTH or INFU? Delcath Systems has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, InfuSystem has a beta of 1.9, suggesting that its stock price is 90% more volatile than the S&P 500. Does the MarketBeat Community believe in DCTH or INFU? Delcath Systems received 24 more outperform votes than InfuSystem when rated by MarketBeat users. However, 100.00% of users gave InfuSystem an outperform vote while only 27.50% of users gave Delcath Systems an outperform vote. CompanyUnderperformOutperformDelcath SystemsOutperform Votes3327.50% Underperform Votes8772.50% InfuSystemOutperform Votes9100.00% Underperform VotesNo Votes Do insiders & institutionals believe in DCTH or INFU? 61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 71.1% of InfuSystem shares are owned by institutional investors. 17.9% of Delcath Systems shares are owned by insiders. Comparatively, 10.2% of InfuSystem shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryInfuSystem beats Delcath Systems on 13 of the 19 factors compared between the two stocks. Remove Ads Get InfuSystem News Delivered to You Automatically Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INFU vs. The Competition Export to ExcelMetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$106.55M$4.19B$5.29B$18.52BDividend YieldN/A44.80%5.34%4.00%P/E Ratio84.5128.8222.0231.42Price / Sales0.7943.71349.0427.05Price / Cash12.7951.0838.1517.54Price / Book2.055.816.244.31Net Income$870,000.00$67.09M$3.19B$1.02B7 Day Performance-4.70%-4.60%-4.11%-6.77%1 Month Performance-17.02%-6.67%-2.47%-7.65%1 Year PerformanceN/A9.54%3.85%-2.67% InfuSystem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INFUInfuSystem1.3763 of 5 stars$5.07+5.6%$13.00+156.4%N/A$106.55M$134.86M84.51410High Trading VolumeDCTHDelcath Systems3.1278 of 5 stars$12.73-3.2%$22.75+78.7%+106.2%$425.22M$37.21M-9.4360News CoveragePositive NewsHigh Trading VolumeNPCENeuroPace3.0204 of 5 stars$12.29+3.7%$15.20+23.7%-27.6%$400.16M$79.91M-12.29170Analyst RevisionNews CoverageGap DownSMLRSemler Scientific3.299 of 5 stars$36.20-1.8%$71.00+96.1%+13.7%$347.41M$56.29M7.37120News CoveragePositive NewsCLPTClearPoint Neuro1.6862 of 5 stars$11.89-0.7%$25.00+110.3%+67.4%$328.54M$31.39M-17.23110High Trading VolumeCVRXCVRx2.4704 of 5 stars$12.23-2.1%$17.83+45.8%-66.7%$318.42M$51.29M-4.55160Analyst ForecastNews CoveragePositive NewsGap DownTCMDTactile Systems Technology3.0915 of 5 stars$13.22+1.7%$18.00+36.2%-16.6%$311.79M$292.98M18.89980SNWVSANUWAVE HealthN/A$35.37-3.2%N/AN/A$302.38M$32.63M-9.0740News CoveragePositive NewsZIMVZimVie2.3578 of 5 stars$10.80-1.0%$23.00+113.0%-45.9%$300.75M$449.75M-0.822,700Analyst ForecastNews CoveragePositive NewsGap DownNNOXNano-X Imaging1.651 of 5 stars$4.99-4.6%$13.50+170.5%-62.1%$288.32M$10.68M-5.87190Gap DownSMTISanara MedTech1.4338 of 5 stars$30.87+2.3%$48.50+57.1%-20.5%$274.81M$86.67M-31.1860 Remove Ads Related Companies and Tools Related Companies DCTH Competitors NPCE Competitors SMLR Competitors CLPT Competitors CVRX Competitors TCMD Competitors SNWV Competitors ZIMV Competitors NNOX Competitors SMTI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INFU) was last updated on 4/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
